Skip to main content
. 2021 Dec 14;10(24):5857. doi: 10.3390/jcm10245857

Figure 4.

Figure 4

Number of patients transferred from sub-intensive to intensive care: in the group treated with PRM 2 mg, only 7.5% (a) versus 15% (c) of the un-treated group were transferred to intensive care due to clinical worsening, and 15% of the untreated group (d) died versus 7.5% of the treated group (b).